Cargando…
Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
BACKGROUND: Glypican-3 (GPC3) is a newly identified target molecule for the early diagnosis of hepatocellular carcinoma (HCC), while targeted inhibition of GPC3 signaling may help to control the proliferation and metastasis of HCC cells. The purpose of this study was to prepare the anti-GPC3 nanobod...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125335/ https://www.ncbi.nlm.nih.gov/pubmed/32280214 http://dx.doi.org/10.2147/IJN.S235058 |